<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Angelis Consulting Group | Fitzpatrick | Activity</title>
	<link>https://angelisconsulting.com/members/motionvision92/activity/</link>
	<atom:link href="https://angelisconsulting.com/members/motionvision92/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Fitzpatrick.</description>
	<lastBuildDate>Sun, 30 Aug 2026 04:23:17 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4634a65eaa91172ff4454bf410cec545</guid>
				<title>Fitzpatrick posted an update: Understanding the Legal Landscape: Separating Fact from [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/51308/</link>
				<pubDate>Mon, 17 Aug 2026 20:05:18 -0500</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Legal Landscape: Separating Fact from Fiction in Multiple Myeloma Litigation</p>
<p>The medical diagnosis of Multiple Myeloma (MM), a major cancer of plasma cells in the bone marrow, is unquestionably overwhelming. Beyond the medical challenges, patients and their families frequently come to grips with concerns of cause,&hellip;<span class="activity-read-more" id="activity-read-more-51308"><a href="https://angelisconsulting.com/activity/p/51308/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2e2ecf5ac0e0fa76fd409bb5dd58d6c9</guid>
				<title>Fitzpatrick posted an update: Understanding Multiple Myeloma Settlements: What Patients and [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/51166/</link>
				<pubDate>Mon, 17 Aug 2026 19:28:31 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Understanding Multiple Myeloma Settlements: What Patients and Families Need to Know</strong> </p>
<p><em>A helpful, third‑person summary of how legal settlements occur in multiple‑myeloma cases, what they generally cover, and what actions affected people can consider.</em> </p>
<p>Introduction</p>
<p>Multiple myeloma&#8211; a cancer of plasma cells in the bone marrow&#8211; has act&hellip;<span class="activity-read-more" id="activity-read-more-51166"><a href="https://angelisconsulting.com/activity/p/51166/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a63a1c1aedd7d4382472f37f7cd110e7</guid>
				<title>Fitzpatrick posted an update: Navigating the Complexities: Why a Specialized Multiple [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/50958/</link>
				<pubDate>Mon, 17 Aug 2026 18:49:22 -0500</pubDate>

									<content:encoded><![CDATA[<p>Navigating the Complexities: Why a Specialized Multiple Myeloma Attorney is Crucial for Affected Patients</p>
<p>Getting a diagnosis of multiple myeloma is undoubtedly life-altering. This aggressive cancer of plasma cells in the bone marrow brings tremendous physical, psychological, and monetary burdens. While improvements in treatment offer hope,&hellip;<span class="activity-read-more" id="activity-read-more-50958"><a href="https://angelisconsulting.com/activity/p/50958/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">132fa6d6700c82860b600c69b8465630</guid>
				<title>Fitzpatrick became a registered member</title>
				<link>https://angelisconsulting.com/activity/p/50926/</link>
				<pubDate>Mon, 17 Aug 2026 18:44:55 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>